The American & Global College of Endometriosis Specialists (AGCES) 2026 Conference is shaping up to be one of the most important global gatherings focused on endometriosis and adenomyosis education, innovation, and collaboration. Taking place March 19–21, 2026 at the Fontainebleau Hotel in Las Vegas, NV, this landmark meeting brings together
Uncategorized
About Endometriosis & the Global EndoMarch Movement
ENDOMARCH DAY 2025 – SATURDAY, MARCH 29, 2025 ENDOMARCH-AGCES CONFERENCE – ATLANTA, MARCH 28-30, 2025 Global Endometriosis March to End Endometriosis Healthcare Inequities Join tens of thousands of Endometriosis Resistance Fighters Survivors and their families from around the world for the 12th Annual Worldwide EndoMarch Virtual March & ENDOMARCH-AGCES ATLANTA
Flawed endometriosis research leads to decades of under-reporting of endometriosis-associated cancer risk
Improper stratification obscures true extent of risk for specific subtypes of endometriosis: Nearly 120 years ago, pioneering endometriosis specialists, like Dr. Thomas Cullen, were already thinking about endometriosis subtype risk stratification concepts after noticing a potential association between histologically atypical endometriosis* and an elevated incidence of certain cancers. By 1925,
Endometrioma/Chocolate Cyst vs Hemmorhagic Ovarian Cyst: Which is it or both?
One of the most common ways endometriosis patients get sent down decade-long (or more!) diagnostic derailments is when their endometriotic ovarian cyst (endometrioma/chocolate cyst) is misdiagnosed as a hemorrhagic ovarian cyst – or other forms of usually (but not always!) harmless, so-called ‘normal functional ovarian cysts.’* To the untrained eye,